Skip to main content

Day: July 24, 2024

NV5 Awarded $10 Million in North Carolina Department of Transportation Infrastructure Contracts

HOLLYWOOD, Fla., July 24, 2024 (GLOBE NEWSWIRE) — NV5 Global, Inc. (the “Company” or “NV5”) (Nasdaq: NVEE), a provider of compliance, technology, engineering, and environmental consulting solutions, announced today that it has been awarded $10 million in contracts by the North Carolina Department of Transportation (NCDOT) to advance key infrastructure projects throughout the state. “NV5’s DOT Growth Initiative was launched in 2023 to ensure that our most highly qualified engineers and technical professionals are in direct communication with our clients to provide unmatched technical expertise,” said Dickerson Wright, PE, Executive Chairman of NV5. “NV5 has supported NCDOT for over 25 years, and the continued expansion of our relationship with NCDOT is a direct result of our commitment to delivering high-quality solutions to support...

Continue reading

Madrigal Pharmaceuticals to Release Second-Quarter 2024 Financial Results and Host Webcast on August 7, 2024

CONSHOHOCKEN, Pa., July 24, 2024 (GLOBE NEWSWIRE) — Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) announced today that it will release its second-quarter 2024 financial results on Wednesday, August 7, 2024, prior to the open of the U.S. financial markets. Following the announcement, Madrigal’s management will host a live webcast at 8 a.m. Eastern Time to review the Company’s financial and operating results. The live webcast may be accessed at the Investor Relations section of the Madrigal Pharmaceuticals website. To ensure a timely connection, it is recommended that participants register at least 15 minutes prior to the scheduled webcast. The webcast will be available approximately two hours after the live webcast. About Madrigal Pharmaceuticals Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) is a biopharmaceutical company pursuing...

Continue reading

Intermex (NASDAQ: IMXI) Welcomes New Leadership and Sales Talent

MIAMI, July 24, 2024 (GLOBE NEWSWIRE) — International Money Express, Inc. (NASDAQ: IMXI) (“Intermex” or the “Company”), a leading provider of money remittance services, is excited to announce the addition of two new senior leaders to its team. These strategic hires underscore Intermex’s commitment to growth, innovation, and exceptional service in the remittance industry. Intermex is pleased to announce that Chris Kawula has joined the Company as the new Executive Vice President, Head of Sales. This critical position, reporting directly to Chief Executive Officer Bob Lisy, is instrumental in executing Intermex’s highly differentiated retail sales strategy, driving customer and partner acquisition, and ensuring top-notch service across Intermex’s US retail business. Chris brings extensive leadership...

Continue reading

Annovis Bio Secures U.S. Patent for Treatment of Acute Traumatic Brain Injury with Buntanetap

MALVERN, Pa., July 24, 2024 (GLOBE NEWSWIRE) — via IBN – Annovis Bio Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative disorders such as Alzheimer’s disease (AD) and Parkinson’s disease (PD), announced today the issuance of a U.S. patent for methods of treating acute traumatic brain injuries (TBI) with its lead drug candidate, buntanetap. In 2016, the Company filed a patent covering the treatment of various nerve insults, including TBI, stroke, and nerve and spinal cord injuries. While these claims were granted in Europe and worldwide, the U.S. Patent and Trademark Office (USPTO) required the claims to be divided into individual patents for each indication. Annovis Bio has now received U.S. Patent No. 12,042,482, which covers methods...

Continue reading

Fly-E Group, Inc. to Launch Three New Electric Motorcycle Models

NEW YORK, July 24, 2024 (GLOBE NEWSWIRE) — Fly-E Group, Inc. (Nasdaq: FLYE) (“Fly-E” or the “Company”), an electric vehicle company engaged in designing, installing and selling smart electric motorcycles, electric bikes, electric scooters, and related accessories, today announced the upcoming launch of three new electric motorcycle models. These models, the DP, EK PRO, and DT, are scheduled for official unveiling and launch in New York at the end of October 2024.The DP model is designed for riders seeking high performance, offering exceptional speed and efficiency. The EK PRO model combines technology with a sleek design, providing an enhanced riding experience for electric motorcycle enthusiasts. The DT model is built for adventure, featuring robust specifications for off-road terrains to ensure durability...

Continue reading

SolarMax Technology, Inc. Plans to Offer EPC Services in the United States

RIVERSIDE, Calif., July 24, 2024 (GLOBE NEWSWIRE) — SolarMax Technology, Inc. (Nasdaq SMXT) (“SolarMax” or the “Company”), an integrated solar energy company, announced that it plans to offer engineering, procurement and construction services, known as EPC services, for large scale solar systems in the United States, which would include both solar power and EV charging stations. As the initial step in this business plan, SolarMax has signed a non-binding memorandum of understanding for its first major commercial solar installation project in the United States. This proposed project, to be located in Las Vegas, marks a potentially significant milestone in SolarMax’ strategy to offer large scale EPC services in the U.S. EPC services encompass the comprehensive management of a solar project from the initial feasibility studies and...

Continue reading

SMC Announces Exchange of $516,004 of Debt to Preferred Equity

BOCA RATON, Fla., July 24, 2024 (GLOBE NEWSWIRE) — SMC Entertainment, Inc. (“SMC” or the “Company”) (OTC: SMCE), a versatile incubator company focused on acquisition and support of proven commercialized financial services and technology (Fintech) companies, is pleased to announce the exchange of $516,004 of debt in the form of convertible promissory notes (the “Debt”) for Series D Preferred Shares (“Preferred Shares”). The Debt exchanged to Preferred Shares will be reflected in the Company’s third-quarter 2024 financial statements. The Debt is comprised of $516,004 held in two previous convertible notes; $313,323 and $202,681 respectively. The Company shall issue 55,000 Preferred Shares in exchange for the Debt. The Preferred Shares shall convert into the Company’s common stock at a share price of the lesser of $0.005 or 65% of...

Continue reading

AMSC Receives Wind Turbine Electrical Control System Follow-on Order from Inox Wind

3 MW Class Electrical Control Systems to Serve Growing Onshore Wind Market in India AYER, Mass., July 24, 2024 (GLOBE NEWSWIRE) — AMSC (NASDAQ: AMSC), a leading system provider of megawatt-scale power resiliency solutions that orchestrate the rhythm and harmony of power on the grid™, and protect and expand the capability of our Navy’s fleet, today announced it has received an order worth over $12 million for its 3 megawatt (MW) class wind turbine electrical control systems (ECS) from Inox Wind Limited (Inox), India’s premium wind turbine manufacturer. AMSC expects to ship most of these ECS over the course of fiscal year 2024. “Demand from India’s growing wind market is strong and projected to grow. We are reporting our highest backlog in recent memory with nearly 2.7 gigawatts of orders and are delighted to place a larger...

Continue reading

Spectral AI Announces Total U.S. and International Patent Portfolio Now Stands at 26 Granted Patents and 38 Pending Applications in Support of its AI-Driven DeepView System

DALLAS, July 24, 2024 (GLOBE NEWSWIRE) — Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced a 30% increase in its patent portfolio that strengthens and protects its proprietary, AI-driven DeepView System wound assessment platform. Total patents granted to the Company increased to 26 through July 8, 2024 from 20 at December 31, 2023, consisting of 12 U.S. and 14 international patents. These patents cover various aspects of the Company’s DeepView System platform, including, but not limited to, tissue classification based on multi-spectral imaging, machine learning and healthcare metrics, wound assessments based on multi-spectral imaging, optical biomarkers, machine...

Continue reading

Health Catalyst to Announce Second Quarter 2024 Operating Results and Host Conference Call on Wednesday, August 7, 2024

SALT LAKE CITY, July 24, 2024 (GLOBE NEWSWIRE) — Health Catalyst, Inc. (“Health Catalyst”, Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its second quarter 2024 operating results on Wednesday, August 7, 2024, after market close. In conjunction, the company will host a conference call to review the results at 5 p.m. E.T. on the same day. Conference Call Details The conference call can be accessed by dialing 800-267-6316 for U.S. participants, or 203-518-9783 for international participants, and referencing conference ID “HCATQ224.” A live audio webcast will be available online at https://ir.healthcatalyst.com/. A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call, at the same web link,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.